Anti-PAD1 Polyclonal Antibody

Anti-PAD1 Polyclonal Antibodyis available at Gentaur for Next week Delivery.

Description: Protein arginine deiminases (PADs) are guanidine-modifying enzymes that catalyze the post-translational modification of target proteins by converting arginine to citrulline. Excessive citrullination of proteins may result in disease states. PAD1 is expressed in uterus and throughout the epidermis, and is involved in the late stages of epidermal differentiation and possibly hair follicle formation. Disruption in PAD1 activity is associated with certain skin diseases and Laing Distal Myopathy.

Immunogen Sequence:Recombinant fusion protein containing a sequence corresponding to amino acids 1-260 of human PADI1

Target Alternative Name:Peptidyl Arginine Deiminase 1; PDI1; Protein-Arginine Deiminase Type I; Peptidylarginine Deiminase I; HPAD-Colony 10; EC 3.5.3.15; HPAD10; PDI; PADI1

Species Reactivities:Human Mouse

Tag Line:Catalyzes the conversion of arginine into citrulline in distinct proteins

Formulation:In PBS with 0.02% sodium azide, 50% glycerol, pH 7.3

Purification: Affinity purification

Application:Western Blotting

Positive Control:/

Application And Usages:/

Handling:The antibody solution should be gently mixed before use.